EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bone and joint tuberculosis: clinical manifestation, diagnostic techniques and drug resistance analysis

Yingying Yuan, Pengxiang Li, Xiangjie Qiu, Honghua Zhang, Hao Chen, Nan Zang, Wenbo Li, Meijin Cheng, Zhen Guo, Xiaodong Niu, Yue Zhao, Xiuli Cao und 2 weitere

Frontiers in Cellular and Infection Microbiology · 21.11.2025 · 15

DOI: 10.3389/fcimb.2025.1687906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 21.11.2025. Verfasst von Yingying Yuan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Henan Provincial Chest Hospital, Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Osteoarticular, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Clinical data on bone and joint tuberculosis (BJTB) in developing countries remain limited. This study aims to investigate the clinical, epidemiological, and drug-resistance characteristics of BJTB patients in Central China and to optimize diagnostic strategies.

Methods

This retrospective study analyzed data from patients diagnosed with BJTB at Henan Provincial Chest Hospital between 2016 and 2022.

Results

Among the 902 patients, 518 (57.4%) were male and 384 (42.6%) were female. The age groups of 21–30 years and 51–60 years, as well as the rural population, showed the highest prevalence of cases. Local pain was the most prevalent symptom, followed by fever, night sweats, and neurological dysfunction. On average, the time from symptom onset to diagnosis was 6.1 months, and the mean hospital stay was 64.2 days. Spinal tuberculosis was the most frequently affected site, accounting for 77.6% (700/902) of cases. Five diagnostic techniques were evaluated, with GeneXpert MTB/RIF demonstrating superior performance by achieving a sensitivity of 91.6% (95%CI: 86.3%-95.0%) and specificity of 90.1% (95%CI: 85.5%-93.6%). Unlike drug resistance patterns observed in other regions, streptomycin (29.6%) and rifabutin (18.2%) were the most frequently encountered first-line and second-line anti-tuberculosis drugs, respectively. The prevalence of multidrug-resistant tuberculosis (MDR-TB) was 8.3% (95% CI: 5.1%–13.2%), and extensively drug-resistant tuberculosis (XDR-TB) was identified in 1.6% (95% CI: 0.2%-5.6%) of cases.

Conclusions

The application of GeneXpert MTB/RIF demonstrated significant diagnostic accuracy for BJTB. The control of MDR-TB remains a critical challenge in the management of BJTB in Central China.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, OsteoarticularTuberculosis, Multidrug-ResistantHumansFemaleMaleAdultRetrospective StudiesMiddle AgedYoung AdultChinaAntitubercular AgentsPrevalenceAgedAdolescentSensitivity and SpecificityMicrobial Sensitivity TestsChild

Stichwörter der Autor:innen

GeneXpert MTB/RIFMycobacterium tuberculosisbone & joint tuberculosisdrug resistanceosteoarticular tuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Henan Provincial Chest Hospital, Zhengzhou University, Zhengzhou, China.
  • Henan Provincial Key Laboratory of Tuberculosis Diagnostic Medicine, Zhengzhou, China.
  • Henan Provincial Infectious Diseases (Tuberculosis) Clinical Medical Research Center, Zhengzhou, China.
  • Cardiac Surgery Intensive Care Unit, Henan Provincial Chest Hospital, Zhengzhou University, Zhengzhou, China.
  • Department of thoracic surgery, Henan Provincial Chest Hospital, Zhengzhou University, Zhengzhou, China.

Zitieren

APA

Yuan, Y., Li, P., Qiu, X., Zhang, H., Chen, H., Zang, N., Li, W., Cheng, M., Guo, Z., Niu, X., Zhao, Y., Cao, X., Han, Y., & Wang, W. (2025). Bone and joint tuberculosis: clinical manifestation, diagnostic techniques and drug resistance analysis. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1687906

Vancouver

Yuan Y, Li P, Qiu X, Zhang H, Chen H, Zang N, et al. Bone and joint tuberculosis: clinical manifestation, diagnostic techniques and drug resistance analysis. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1687906

BibTeX
@article{Yuan2025,
  author = {Yuan, Yingying and Li, Pengxiang and Qiu, Xiangjie and Zhang, Honghua and Chen, Hao and Zang, Nan and Li, Wenbo and Cheng, Meijin and Guo, Zhen and Niu, Xiaodong and Zhao, Yue and Cao, Xiuli and Han, Yungang and Wang, Wei},
  title = {Bone and joint tuberculosis: clinical manifestation, diagnostic techniques and drug resistance analysis},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1687906}
}
Kostenlos starten →